Viridian Therapeutics, Inc. (VRDN)
32.90
+0.72
(+2.25%)
USD |
NASDAQ |
Jan 23, 16:00
33.20
+0.30
(+0.93%)
After-Hours: 20:00
Viridian Therapeutics Research and Development Expense (TTM): 321.22M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 14.74M |
| ADMA Biologics, Inc. | 3.776M |
| Orthofix Medical, Inc. | 69.28M |
| Avantor, Inc. | -- |
| Immunovant, Inc. | 403.62M |